Patent details
301113
Product Name:
Tucatinib, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout of solvaat
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
301113
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1971601
Status:
SPC granted but not yet in force
Application number:
301113
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)
Marketing Authorization
1
Marketing Authorization Number:
67798
Marketing Authorization Type:
EEA
Marketing Authorization Date:
07/05/2020
Marketing Authorization Country:
Switzerland (CH)
2
Marketing Authorization Number:
EU/1/20/1526
Marketing Authorization Type:
EEA
Marketing Authorization Date:
12/02/2021
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
06/07/2021
First Marketing Authorization date:
07/05/2020
Grant date:
03/08/2021
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
06/07/2021
SPC/SPC Extension Expiration Date:
14/11/2031
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
06/07/2021
Name:
Array Biopharma, Inc.
Address:
3200 Walnut Street, 80301, Boulder, Colorado, United States of America (US)
Agent
Name:
ir. M.F.J.M. Ketelaars c.s.
From:
06/07/2021
Address:
NLO
Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
SPC
Journal edition number:
31/21
Publication date:
04/08/2021
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
2
Bulletin Heading:
SPC
Journal edition number:
27/21
Publication date:
07/07/2021
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Annual Fee
Annual Fee(s) Due Date:
30/11/2026
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date
Document type
Document Description
Number of pages
File Type
03/08/2021
Certificate
Certificate
1
PDF
/4/0/8/9/9/0800699804/docs/301113_8_spcmedcertificate20210803105900392.pdf
03/08/2021
Outgoing Correspondence
Decision grant
2
PDF
/4/0/8/9/9/0800699804/docs/301113_9_427151l504a.pdf
06/07/2021
SPC Documents
Annex SPC
3
PDF
/4/0/8/9/9/0800699804/docs/301113_0_supplprotectioncertificate20210706043543375.pdf
06/07/2021
SPC Documents
Annex SPC
16
PDF
/4/0/8/9/9/0800699804/docs/301113_1_supplprotectioncertificate20210706043543447.pdf
06/07/2021
SPC Documents
Annex SPC
39
PDF
/4/0/8/9/9/0800699804/docs/301113_2_supplprotectioncertificate20210706043136632.pdf
06/07/2021
SPC Documents
Marketing Authorization SPC
4
PDF
/4/0/8/9/9/0800699804/docs/301113_3_supplprotectioncertificate20210706043029511.pdf
06/07/2021
SPC Documents
Marketing Authorization SPC
3
PDF
/4/0/8/9/9/0800699804/docs/301113_4_supplprotectioncertificate20210706042945332.pdf
06/07/2021
Application Form
First filed application form
2
PDF
/4/0/8/9/9/0800699804/docs/301113_5_applicationform20210706042714060.pdf
06/07/2021
SPC Documents
Summary of the characteristics of the product
19
PDF
/4/0/8/9/9/0800699804/docs/301113_6_supplprotectioncertificate20210706043543279.pdf
06/07/2021
Outgoing Correspondence
Confirmation receipt request
1
PDF
/4/0/8/9/9/0800699804/docs/301113_7_421666l174.pdf
06/07/2021
SPC Documents
Annex SPC
3
PDF
/4/0/8/9/9/0800699804/docs/301113_10_supplprotectioncertificate20210706043633722.pdf